Tumor promoter, TPA, enhances replication of HTLV-III/LAV
- 1 October 1986
- Vol. 154 (2) , 249-258
- https://doi.org/10.1016/0042-6822(86)90451-4
Abstract
No abstract availableFunding Information
- Ministry of Education and Science
- Ministry of Health, Labour and Welfare
This publication has 27 references indexed in Scilit:
- Enteric infections and other cofactors in AIDSImmunology Today, 1985
- Selective cytotoxicity of aids virus infection towards HTLV-I-transformed cell linesInternational Journal of Cancer, 1985
- Infection of human T-lymphotropic virus type-1 (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): Chronological studies of early eventsVirology, 1985
- The Epidemiology of AIDS: Current Status and Future ProspectsScience, 1985
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981
- Mechanism of enhancement of epstein‐barr virus‐induced transformation of peripheral blood lymphocytes by a tumor promoter, tpa, with special reference to lowering of cytotoxicity of t cellsInternational Journal of Cancer, 1981
- Tumour promoter induces anchorage independence irreversiblyNature, 1979